Clinical Trials Logo

Citation(s)

  •   Adams CE, Stevens KE
    Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front Biosci. 2007 May 1;12:4755-72. Review.
  •   Apud JA, Weinberger DR
    Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors. CNS Drugs. 2007;21(7):535-57. Review.
  •   Arinami T, Ishiguro H, Onaivi ES
    Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur J Pharmacol. 2000 Dec 27;410(2-3):215-226. Review.

Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia

Details for clinical trial NCT01034085